Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Roche Molecular Systems

Roche Molecular Systems

Roche Molecular Systems is a company developing, manufacturing and supplying diagnostic and blood screening tests

Roche Molecular Systems is a company developing, manufacturing and supplying diagnostic and blood screening tests. The company was founded in 1991 in Pleasanton, California, United States, and is a sub-organization of Roche.

The company develops and commercializes diagnostic and blood screening tests based on polymerase chain reaction technologies. Roche Molecular Systems creates products including vitro diagnostic PCR kits, research assays, and automation platforms for the PCR kit processing.

COVID-19

Since the outbreak of COVID-19 (coronavirus), Roche Molecular Systems has begun commercial testing for drugs to combat the virus. The company is looking to provide high-volume testing capabilities to respond to the pandemic, and has been working to bring their cobas 6800/8800 systems test to their patients as the test can perform a SARS-CoV-2 test within three to four hours. The company plans to have millions of tests available each month for the cobas 6800 and 8800 systems. Expediting test development to support urgent needs during the outbreak is the top priority for Roche Molecular Systems.

Timeline

Patents

Further Resources

Title
Author
Link
Type
Date

Molecular Diagnostics

Web

Pleasanton Company Creates Coronavirus Test Kits

Marianne Favro

Web

March 14, 2020

Roche's cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

Web

References

Golden logo
By using this site, you agree to our Terms & Conditions.